In a new study from the University of Padova in Italy, researchers found that there is a high prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease (IBD).
The team conducted a systematic review of data from studies of more than 100 adult patients with IBD that reported on the prevalence of symptoms of anxiety or depression.
Based on 77 studies (30,118 patients), the researchers found that overall, the prevalence of anxiety symptoms was 32.1% in 58 studies; the prevalence of depression symptoms was 25.2% in 75 studies.
Among studies that reported prevalence of anxiety or depression in patients with Crohn’s disease and ulcerative colitis, patients with Crohn’s disease had higher odds of anxiety symptoms and depression symptoms compared with patients with ulcerative colitis.
In addition, women were more likely than men with IBD to have symptoms of anxiety (33.8% for women versus 22.8% for men).
Women were also more likely than men to have symptoms of depression (21.2% for women versus 16.2% for men).
The team says the findings can help gastroenterologists to screen for and treat these disorders and might improve outcomes for patients with IBD.
If you care about depression and anxiety, please read studies about this popular supplement may help reduce depression and findings of new treatment for depression, anxiety.
For more information about mental health, please see recent studies about single dose cannabis THC may lead to depression, anxiety and results showing that Stanford scientists rapidly reduce depression with this treatment.
The study is published in The Lancet Gastroenterology & Hepatology. One author of the study is Brigida Barberio, M.D.
Copyright © 2021 Knowridge Science Report. All rights reserved.
